Society Information

ETRO

Thrombosis Research is the Official Journal of European Thrombosis Research Organisation (ETRO), is an international non-profit organisation, that aims to promote education and scientific research on all aspects of thrombosis and haemostasis.

This is done by facilitation of

  • scientific exchange between the participating institutions,
  • organization of scientific meetings and workshops,
  • coordination of specific research activities and joint research projects,
  • provision of information on equipment and methods in the member laboratories
  • encouragement of a visitor exchange program
  • establishment of contacts with other organizations, authorities and institutions with an interest in thrombosis and haemostasis.

Link to website: http://www.etro.eu.org/

XI ETRO Advanced Teaching Course Thrombosis: a multidisciplinary approach
18-23 September 2011, Campobasso — Hotel Centrum Palace, Italy


MLTD

The Mediterranean League against thromboembolic diseases (MLTD) is a multidisciplinary non-profit Scientific Society with a great tradition, created more than 40 years ago with the aim to promote the scientific advance and dissemination of knowledge in the diagnosis, prophylaxis and treatment of Thrombosis and Haemostasis.

22nd International Congress on Thrombosis


NATF

North American Thrombosis Forum

The North American Thrombosis Forum’s (NATF) mission is to focus on unmet needs and issues related to thrombosis and cardiovascular disease such as deep vein thrombosis, pulmonary embolism, myocardial infarction, peripheral arterial occlusive disease, and stroke. NATF’s five areas of major focus are:

  • Education and Prevention
  • Public Policy
  • Clinical research, focusing on diagnosis and therapy
  • Basic translational research
  • Advocacy

The NATF vision is to improve patient care, outcomes, and public health by utilizing a multidisciplinary approach to advance thrombosis research and education. NATF programs encourage collaboration among translational researcher, clinical researchers, healthcare professionals, policy makers and patients.